GLP-1 SEMA

Semaglutide (GLP-1 Receptor Agonist)

Product Overview

Semaglutide is a highly advanced, long-acting GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the native incretin hormone. Engineered with a specialized C18 fatty diacid chain, this peptide binds to serum albumin to significantly extend its half-life, allowing for sustained, once-weekly application profiles. It is a premier compound for researching the metabolic pathways involved in blood glucose regulation, profound appetite suppression, and energy homeostasis.

Technical Specifications

• Molecular Formula: C187H291N45O59

• Molecular Weight: 4113.58 g/mol

• CAS Number: 910463-68-2

• Sequence Profile: 31-amino acid modified peptide featuring a C18 fatty diacid chain attached via a mini-PEG linker
  

Mechanism of Action

Semaglutide exerts its effects by activating GLP-1 receptors throughout the body, providing continuous engagement rather than transient postprandial spikes:

• Pancreatic Function: Enhances glucose-dependent insulin secretion while suppressing glucagon release.

• Central Nervous System: Crosses the blood-brain barrier to target hypothalamic satiety centers, deeply suppressing appetite and reducing food reward signaling.

• Gastrointestinal Tract: Slows gastric emptying, prolonging satiety and modulating glucose absorption rates.

🚚 📦 Availability 

At CNL, we believe quality is worth the wait. Instead of stocking products and have them sit for months, most orders are produced in small batches to maintain the quality and consistency our customers expect.

Production typically takes approximately two weeks. While this isn't the norm in today's world of overnight delivery, it's how we deliver the premium quality we're known for.

Limited inventory may be available for immediate shipment after large production runs or special promotions.

As a thank you for your patience, we offer bundle discounts of up to 50% OFF.

⚠️ Important Disclaimer for Carbon Nova Labs Customers: All information provided is for educational and reference purposes only. Semaglutide is sold strictly for laboratory research use only. This compound is not approved by the FDA for human consumption, therapeutic use, or clinical application. Ensure compliance with all institutional safety protocols and consult qualified professionals before conducting research.